NCT00586430View on ClinicalTrials.gov

The Impact of Lorazepam on Cognition in APOE e4 Carriers

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

lorazepam

single 2 mg dose of lorazepam

DRUG

placebo

single dose of placebo

Trial Locations (1)

85259

Mayo Clinic, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Mayo Clinic

OTHER

NCT00586430 - The Impact of Lorazepam on Cognition in APOE e4 Carriers | Biotech Hunter | Biotech Hunter